Publications by authors named "J G Dalton"
Freshwater ecosystems are highly biodiverse and important for livelihoods and economic development, but are under substantial stress. To date, comprehensive global assessments of extinction risk have not included any speciose groups primarily living in freshwaters. Consequently, data from predominantly terrestrial tetrapods are used to guide environmental policy and conservation prioritization, whereas recent proposals for target setting in freshwaters use abiotic factors.
View Article and Find Full Text PDFStudy Design: Retrospective cohort.
Objective: To analyze the annual trends in the most prevalent topics, journals, and geographic regions of the top 100 spine surgery articles, as determined by altmetric attention scores (AASs). We also describe the relationship between AAS and traditional article metrics.
Study Design: Retrospective cohort study.
Objective: To evaluate inpatient complication profiles of patients receiving neuromuscular blockade reversal via sugammadex versus neostigmine/glycopyrrolate.
Summary Of Background Data: Sugammadex is a neuromuscular blockade reversal agent that binds non-depolarizing muscle relaxants.
Article Synopsis
- 2-Phenylbenzimidazole-5-sulfonic acid (PBSA) and disodium phenyl dibenzimidazole tetrasulfonate (DPDT) are UV sunscreen filters that can release harmful high-energy photons, necessitating the use of fluorescence quenchers in formulations.
- Troxerutin is evaluated as a fluorescence quencher for both PBSA and DPDT, with experiments conducted on both solutions and a human skin mimic to benchmark their photodynamics.
- The study reveals that adding troxerutin significantly reduces the fluorescence lifetime of PBSA and DPDT, indicating that it quenches fluorescence via Dexter energy transfer (DET) or Förster resonance energy transfer (FRET) mechanisms.
Study Design: Retrospective cohort.
Objective: To explore the relationship between symptomatic pseudoarthrosis requiring revision after lumbar fusion and antidepressant use.
Summary Of Background Data: Approximately 25% of patients undergoing spine surgery are taking antidepressants.